Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

By Christy Santhosh and Kamal Choudhury (Reuters) -Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into ...

In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

The recent Senate confirmation hearings for Robert F. Kennedy Jr. presented a striking scene that would confuse a time ...

During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...

The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the ...

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

A satirical news headline originally published on SpaceX Mania saying that billionaire Mark Cuban was moving his company Cost ...

These are some of the problems that doctors have encountered in China’s public hospitals. They have been speaking out in recent weeks, questioning the quality of the country’s drugs and urging reform ...

Cole Chapman has been dealing with high drug prices for several years. He has an irregular heartbeat and has to take certain ...